Avp Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Arginine vasopressin (AVP), also known as antidiuretic hormone (ADH), is a 9-amino acid neuropeptide encoded by the AVP gene on chromosome 20p13 that plays critical roles in water retention, blood pressure regulation, and social behavior[1]. Beyond its peripheral endocrine functions, AVP acts as a central neuropeptide modulating stress responses, social cognition, memory consolidation, and circadian rhythms—all processes relevant to neurodegenerative diseases.
The AVP gene encodes preprovasopressin, which is processed to mature AVP (arginine vasopressin) along with neurophysin I and a glycopeptide. AVP is synthesized primarily in the supraoptic nucleus (SON) and paraventricular nucleus (PVN) of the hypothalamus[2].
AVP is expressed in brain regions involved in social and homeostatic functions:
| Brain Region | Expression Level | Functional Significance |
|---|---|---|
| Supraoptic Nucleus | Very High | Water balance, stress |
| Paraventricular Nucleus | Very High | HPA axis modulation |
| Bed Nucleus of Stria Terminalis | High | Social behavior |
| Amygdala | Moderate | Emotional processing |
| Hippocampus | Low-Moderate | Memory modulation |
| Lateral Septum | High | Social recognition |
AVP signals through three G-protein coupled receptors (V1a, V1b, V2), with V1a and V1b being primarily expressed in the brain[3]:
AVP system alterations are reported in AD, with changes in receptor expression and peptide levels in specific brain regions[4]. AVP may modulate memory consolidation, and its dysregulation could contribute to cognitive deficits.
AVP is involved in autonomic function, which is affected in PD. Alterations in AVP signaling may contribute to non-motor symptoms including sleep disorders and mood changes.
Central diabetes insipidus results from AVP deficiency due to hypothalamic/pituitary pathology. Treatment involves desmopressin (synthetic AVP analog).
Excess AVP secretion causes hyponatremia. Seen in various conditions including CNS disorders and malignancies.
AVP receptor polymorphisms are associated with anxiety disorders and social behavior traits. V1a antagonists explored for anxiety treatment.
| Drug/Compound | Target | Application | Route |
|---|---|---|---|
| Desmopressin | V2 | Diabetes insipidus | Intranasal, oral |
| Convasopressin | V1a | Vasodilatory shock | IV |
| Tolvaptan | V2 | SIADH, hyponatremia | Oral |
| Relcovaptan | V1a | Preterm labor | Research |
| Nelivaptan | V1b | Depression, anxiety | Research |
AVP system modulation has therapeutic potential:
The study of Avp Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Du Vigneaud V, Gish DT, Katsoyannis PG. A synthetic preparation possessing biological properties possessed by the natural vasopressin. Journal of the American Chemical Society. 1954;76(12):4751-4752.
Burbach JP, Luckman SM, Murphy D, Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophyseal system. Physiological Reviews. 2001;81(3):1197-1267. PMID:11427693.
Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. Journal of Endocrinology. 1998;156(2):223-229. PMID:9511659.
Nakase S, Tatewaki M, Kudo K, et al. Vasopressin in neurodegenerative diseases. Annals of the New York Academy of Sciences. 2008;1144:36-43. PMID:19076362.
Donaldson ZR, Young LJ. The relative contributions of central oxytocin and vasopressin receptor mechanisms to individual differences in social behavior. Behavioral Neuroscience. 2018;132(5):376-386. PMID:29952570.
Engelmann M, Landgraf R, Wotjak CT. The hypothalamic-neurohypophyseal system regulates social behavior. Neuropsychopharmacology. 2019;44(1):31-42. PMID:29967370.
Robinson AG, Verbalis JG. Posterior pituitary. In: Melmed S, ed. Williams Textbook of Endocrinology. 14th ed. Elsevier; 2020:298-332.
Zingg HH, Lefebvre DL. Oxytocin and vasopressin gene expression during gestation and parturition. Advances in Experimental Medicine and Biology. 1998;449:51-57. PMID:9725056.